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Influenza A viruses cause acute respiratory disease in swine. Viruses with H1 hemagglutinin genes from the human seasonal lineage
(δ-cluster) have been isolated from North American swine since 2003. The objective of this work was to study the pathogenesis
and transmission of δ-cluster H1 influenza viruses in swine, comparing three isolates from diﬀerent phylogenetic subclusters,
geographic locations, and years of isolation. Two isolates from the δ2 subcluster, A/sw/MN/07002083/07 H1N1 (MN07) and
A/sw/IL/00685/05 H1N1 (IL05), and A/sw/TX/01976/08 H1N2 (TX08) from the δ1 sub-cluster were evaluated. All isolates caused
disease and were transmitted to contact pigs. Respiratory disease was apparent in pigs infected with MN07 and IL05 viruses;
however, clinical signs and lung lesions were reduced in severity as compared to TX08. On day 5 following infection MN07-
infected pigs had lower virus titers than the TX08 pigs, suggesting that although this H1N1 was successfully transmitted, it may
not replicate as eﬃciently in the upper or lower respiratory tract. MN07 and IL05 H1N1 induced higher serum antibody titers than
TX08. Greater serological cross-reactivity was observed for viruses from the same HA phylogenetic sub-cluster; however, antigenic
diﬀerences between the sub-clusters may have implications for disease control strategies for pigs.
1. Introduction
Influenza A viruses are important infectious agents for
humans, avian species, and many mammalian species, in-
cluding swine. In swine, influenza virus causes an acute
infection characterized by high morbidity and very low mor-
tality rates [1]. Influenza viruses of the familyOrthomyxoviri-
dae have negative-sense single-stranded eight-segmented
genome encoding for up to twelve structural and accessory
proteins [2]. The triple reassortant internal gene constella-
tion (TRIG) is the common backbone of the swine influenza
viruses currently circulating in North America (for a review,
see Vincent et al., 2008 [3]). Within the TRIG viruses,
a dominant circulating genotype carries the HA and NA
encoding genes of the human seasonal viruses of the H1
lineage (hu-like), identified from pigs in American and
Canadian herds [4]. The HA genes of these viruses form
the δ-cluster in phylogenetic analyses of HA genes from
North American influenza A viruses of swine. Contemporary
δ-cluster HA genes can be further divided into two sub-
clusters, δ1 and δ2 [5].
Phylogenetically, the HA sequences of American and
Canadian δ-cluster influenza A viruses appeared to have
been derived from at least two independent human-to-pig
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transmission events [3, 6]. The NA genes were also atypical
of classical H1N1 swine viruses, forming a cluster of N1
separate from the swine lineage N1 either andmore similar to
human H1N1 from 2002-2003 or similar to human-like N2
from the same lineage as the triple reassortant H3N2 swine
viruses that emerged in 1997-1998 [3, 6]. However, there
was diversity in the internal genes of the American viruses
compared with Canadian isolates, mainly due to the presence
of the TRIG cassette in the American isolates whereas the
Canadian virus internal genes were classical swine or human
in lineage.
The objective of the work described here was to study the
pathogenesis and transmission of δ-cluster H1 influenza A
viruses of swine in an experimental pig model, comparing
three isolates from diﬀerent locations of the USA (Texas,
Minnesota, and Illinois), diﬀerent collection times (2008,
2007, and 2005, resp.) and with full-length or truncated PB1-
F2 accessory protein. PB1-F2 has been described as virulence
factor for other influenza viruses in other species.
2. Materials and Methods
2.1. Virus Isolates. Three human-like δ-cluster H1 viruses
(two from the δ2 sub-cluster and one from the δ1 sub-
cluster) were used in the in vivo pathogenesis and trans-
mission study. All viruses were isolated from postmortem
lung tissue samples collected from pigs exhibiting clinical
signs of respiratory disease and submitted to the University
of Minnesota Veterinary Diagnostic Laboratory. The two
δ2 sub-cluster H1N1 viruses, A/sw/Minnesota/07002083/07
H1N1 (MN07) and A/sw/Illinois/00685/05 H1N1 (IL05),
were shown to have a predicted truncated PB1-F2 [6],
whereas A/sw/Texas/01976/08 H1N2 (TX08) of the δ1
sub-cluster contained the full-length PB1-F2 coding
sequence [5]. Putative viral protein sequences were highly
conserved within the three viruses using published GenBank
sequences for comparisons (IL05: FJ638301, FJ638299,
FJ638297, FJ638295, FJ638302, FJ638300, FJ638298,
FJ638296; MN07: FJ611902, FJ611900, FJ611898, FJ611896,
FJ611901, FJ611899, FJ611897, FJ611895; TX08: CY082598,
HM461847, HM461848, HM461849, HM461850,
HM461851, HM461852, HM461853, HM461854). Identity
at the amino acid level ranged from 94.8% to 99.0%
with the exception of the NA genes (N1 compared with
N2). The HA proteins had 98.4% identity within the δ2
sub-cluster viruses and 96.8% between the δ1 and δ2
sub-cluster viruses. Three additional δ-cluster isolates were
used for heterologous hemagglutination inhibition (HI)
assays, A/sw/North Carolina/00573/2005 H1N1 (NC05, δ2
sub-cluster), A/sw/Minnesota/02011/2008 H1N2 (MN08,
δ1 sub-cluster), and A/sw/Illinois/07003243/07 H1N2 (IL07,
δ1 sub-cluster). All isolates were propagated in MDCK cells
following standard procedures.
2.2. In Vivo Study. Fifty 3-week-old cross-bred pigs were
obtained from a herd free of influenza A virus and treated
with ceftiofur crystalline-free acid (Pfizer Animal Health,
New York, NY) to reduce bacterial contaminants prior to
the start of the experiment. Pigs were housed in biosafety
level 2 (BSL2) containment during the study and cared for
in compliance with the Institutional Animal Care and Use
Committee of the National Animal Disease Center. Pigs
were divided into seven groups including three groups given
primary inoculation (n = 10 per group) with each of
the three δ-cluster viruses, three contact groups, and one
uninfected control group. Primary pigs at four weeks of age
were inoculated intratracheally with 2 × 105 TCID50/mL of
each virus (2mL of inoculum), and naı¨ve contact pigs (n =
5) were comingled with the primary inoculated pigs after 48
hours. All pigs were observed daily for clinical signs of disease
and fever. Nasal swabs were taken on 0, 3, 5, 7, and 9 days post
infection (dpi) or days post contact (dpc) to evaluate nasal
shedding. Oral fluid (OF) samples were collected from each
of the treatment groups using a cotton rope hung in each pen
on days 3–10, 14, 18, and 20 pi as described previously [7].
The OF samples were assayed for influenza A viral RNA by a
TaqMan real-time PCR assay for the influenza Amatrix gene.
In addition, viral RNA from pooled OF samples obtained at
3–9 dpi or 1–7 dpc was quantified.
Five pigs from each primary inoculated group were
euthanized on day 5 pi to evaluate lung lesions and viral
load in the lung. The remaining pigs (n = 5 per primary
group and n = 5 per contact group) were euthanized
at 21 dpi or 19 dpc. All pigs were humanely euthanized
with a lethal dose of pentobarbital (Sleepaway, Fort Dodge
Animal Health, Fort Dodge, IA). After euthanasia, lungs
were aseptically removed at necropsy and lavaged with
50mL MEM to obtain bronchoalveolar lavage fluid (BALF).
Postmortem samples including serum, lung, and trachea
were collected. Nonchallenged age-matched negative control
pigs were necropsied on day 5 pi (n = 5 pigs).
2.3. Pathologic Examination of Lungs. At necropsy, lungs
were removed and evaluated for typical lesions of influenza
virus infection. The percentage of the surface aﬀected with
pneumonia was visually estimated for each lung lobe, and a
total percentage for the entire lung was calculated based on
weighted proportions of each lobe to the total lung volume
[8]. Tissue samples from the trachea and right cardiac lung
lobe and other aﬀected lobes were taken and fixed in 10%
buﬀered formalin for histopathologic examination. Lung
sections were given a score from 0 to 3 to reflect the severity
of bronchial epithelial injury using previously described
methods [9].
2.4. RNA Extraction from OF Samples. Viral RNA from oral
fluid samples was extracted using the MagMAx Viral RNA
Isolation (Ambion) kit protocol with modifications. Briefly,
clarified oral fluid (300 μL) was added to the MagMax plate
in duplicate and the volumes of the other reagents were
increased proportionally. Isopropanol was omitted from the
lysis/binding buﬀer initially and added after the oral fluid
sample was mixed. RNA was quantified, and the TaqMan
real-time PCR assay for the influenza A virusmatrix gene was
performed following protocol as previously described [10].
Influenza Research and Treatment 3
Pneumonia 5 dpi
TX08 MN07 IL05 Sham
0
5
10
15
20
25
(%
)
∗
(a)
BALF 5 dpi
TX08 MN07 IL05
0
1
2
3
4
5
∗∗
lo
g 1
0
vi
ra
l t
it
er
(b)
Figure 1: (a) Percentage of lung involvement at 5 dpi in pig groups inoculated with TX08, MN07, IL05 and sham. ∗Significantly diﬀerent
from TX08 versus MN07, TX08 versus sham, and IL05 versus sham at P < 0.05. (b) Virus titers in bronchoalveolar lavage fluid (BALF) at
5 dpi for primary inoculated groups. ∗Significantly diﬀerent from TX08 versus MN07 and MN07 versus IL05 at P < 0.05.
Mean quantities of influenza A virus RNA assessed by real-
time RT-PCR of duplicate samples were transformed to log10
scale for comparison.
2.5. Viral Replication and Shedding. Tenfold serial dilutions
in serum-free MEM supplemented with TPCK trypsin and
antibiotics were made with each BALF sample and nasal
swab filtrate sample. Each dilution was plated in triplicate in
100 μL volumes onto PBS-washed confluent MDCK cells in
96-well plates. At 72 hours, plates were fixed and stained for
immunocytochemistry [11]. A TCID50 titer was calculated
for each sample [12].
2.6. Serologic Assays. The homologous and cross-HI assays
were then performed with IL05, MN07, and TX08 as
described previously [13]. In addition, 21 dpi and 19 dpc
sera were evaluated against NC05, IL07, and MN08 in
heterologous HI assays. Reciprocal HI titers were log2
transformed for analysis and reported as geometric means
of the reciprocal titers (5 pigs per group).
2.7. Multicycle Growth Analysis. MDCK cells were infected
in 24-well cell culture plate at low MOI (0.001) with the
three δ-cluster H1 viruses. Supernatants were collected at
6, 12, 24, and 48 hours after infection and subsequently
titrated on MDCK cells as described above. Each virus was
tested in triplicate, and the results are representative of two
independent experiments.
2.8. Statistical Analysis. Analysis of variance (ANOVA) with
a P-value ≤ 0.05 considered significant (GraphPad Prism,
GraphPad Software, La Jolla, CA) was used to analyze
log10 transformed BALF and nasal swab virus titers, log2
transformations of HI reciprocal titers, growth curve, and
macroscopic or microscopic pneumonia scores. Response
variables shown to have a significant eﬀect by treatment
group were subjected to pairwise comparisons using the
Tukey-Kramer test.
3. Results
3.1. Clinical Disease, Macroscopic, Pneumonia and Micro-
scopic Lung Lesion Scores. All viruses induced typical
influenza illness; however, clinical signs and macroscopic
(Figure 1(a)) and microscopic lesions induced by MN07
were reduced in severity as compared to TX08-infected pigs.
IL05-infected lung lesions versus sham showed significant
diﬀerences at P < 0.05. At 5 days post infection (dpi),
microscopic lesions in lungs and tracheas were also typical
of influenza virus infection. Histopathologic lesions in lungs
were characterized by necrotizing bronchiolitis with mild to
moderate interstitial pneumonia. Significant diﬀerences in
histopathological lesions in the trachea were not identified
among groups. Negative control pigs remained negative for
influenza A virus for the duration of the experiment.
3.2. Viral Replication and Transmission Eﬃciency. MN07-
infected pigs had lower virus titers in the lung at 5 dpi
compared to TX08 and IL05 groups. Virus titers in BALF
averaged 104.2 TCID50/mL at 5 dpi in the TX08- and IL05-
inoculated group and 102.6 TCID50/mL at 5 dpi in theMN07-
inoculated group (Figure 1(b)). All inoculated groups shed
virus in nasal swab samples on days 3 and 5 pi. On day 3 pi,
95.5% of nasal swabs were positive with an average titer of
102.4 TCID50/mL in pigs infected with TX08 and MN07 and
101.5 TCID50/mL in pigs infected with IL05 (data not shown).
On day 5 pi, 93% of nasal swabs were positive with an
average titer of 102.4 TCID50/mL for pigs infected with TX08,
101.2 TCID50/mL for pigs infected with MN07, and 101.1
TCID50/mL for pigs infected with IL05 (Figure 2(a)). Pigs
in contact with TX08-infected pigs also shed significantly
more virus in nasal secretions at 5 days post contact (dpc,
Figure 2(a)). On day 7 pi, all nasal swab samples fromMN07-
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Figure 2: Quantity of virus detected in nasal swabs (NT) at 5 dpi (a) or 7 dpi (b) from pigs primarily inoculated (1◦) with TX/08, MN/07, or
IL/05 or in contact (2◦) with inoculated pigs. ∗Significantly diﬀerent from TX08 1◦ (primary) or TX08 2◦ (contact) versus MN07 1◦, MN07
2◦, or IL05 1◦ or IL05 2◦ and MN07 2◦ versus IL05 2◦ at P < 0.05. ∗Significantly diﬀerent from TX08 2◦ versus MN07 1◦, MN07 2◦, or IL05
1◦ at P < 0.05.
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Figure 3: Quantitative influenza A virus real-time RT-PCR of RNA
extracted from oral fluids. Mean quantity of duplicate samples was
transformed to log10 scale.
and IL05-inoculated pigs were negative. In contrast, 80% of
the pigs in the TX08-inoculated group continued to shed
virus in nasal secretions on day 7 pi, with an average titer of
100.7TCID50/mL (Figure 2(b)). In addition, nasal secretions
from TX08 virus contact pigs had higher mean virus titers
at 7 dpc. In the TX08 contact group, 100% of the pigs
had positive nasal swab samples on days 3, 5, and 7 pc,
with average titers of 102.7, 102.1, and 101.8 TCID50/mL,
respectively. Far fewer contact pigs were shedding virus in
the MN07 and IL05 groups, with just 20% and 40% nasal
swab positive, respectively, at 7 dpc. These data demonstrate
that all viruses were able to replicate in the lung and nasal
mucosa; however, nasal shedding of TX08 was greater in
magnitude and duration. In contrast to nasal shedding,
MN07 and IL05 viral RNA was detected more frequently in
OF in comparison to TX08 (Figure 3). The virus shedding
and detection kinetics in OF were diﬀerent when compared
to nasal swabs.
To further evaluate the replicative ability of the δ virus
isolates, we studied the growth of MN07, TX08, and IL05 in
MDCK cells in multicycle growth curve analyses. The three
viruses grew similarly at each time point although viral yields
were significantly diﬀerent (P < 0.05) between TX08 and
MN07 at 24 hours post infection (Figure 4).
3.3. Humoral Immune Response and Cross-Reactivity. Pigs
in this study mounted a more robust humoral immune
response to MN07 and IL-05 δ2 cluster H1N1 viruses
compared to the TX08 in homologous HI assays (Table 1).
Cross-HI using heterologous virus demonstrated little cross-
reactivity between the δ1 TX08 antisera and the δ2 IL05
and MN07 viruses (Table 2). As expected for viruses within
the same sub-cluster and sharing higher similarity, there was
greater cross-reactivity between the MN07 virus and IL05
antisera. Heterologous HI tests using additional H1 δ-cluster
influenza A viruses from swine were conducted to evaluate
cross-reactivity of 21 dpi serum samples from primary
infected pigs (Table 2). The δ1 sub-cluster was represented
by IL07, TX08, and MN08, and the δ2 sub-cluster was
represented by IL05, NC05, and MN07 viruses (Table 2).
As expected, cross-reactivity was found within sub-clusters,
specifically between TX08 antisera and IL07 and between
IL05 and MN07 antisera against IL05, MN07, and NC05
viruses. Results showed little cross-reactivity between MN08
and any of the antisera. The greatest cross-reactivity was
demonstrated between IL07 and TX08 antisera generated
against the H1 δ1 sub-cluster. Antisera from pigs infected
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Figure 4: Multistep growth curves of TX08, MN07, and IL05 in
MDCK cells. Confluent MDCK cells were infected at an MOI
of 0.001 TCDI50/mL. Virus yields (log10 TCDI50/mL) at 6, 12,
24, and 48 h post infection were titrated in MDCK cells. The
results are representative of two independent experiments. Each
virus was treated in triplicate in both experiments. TX08 grew at
statistically significant higher titers with respect MN07 at 24 hours
post infection (P < 0.05).∗Significantly diﬀerent.
Table 1: Results of homologous HI assays using δ-cluster H1
influenza A viruses TX08, MN07, and IL05.
Serum Seroconversion
12 dpc/14 dpi 19 dpc/21 dpi
TX08 H1N2
Primary 5/5 (61) 5/5 (106)
Contact 5/5 (70) 5/5 (80)
MN07 H1N1
Primary 5/5 (211) 5/5 (211)
Contact 5/5 (279) 5/5 (368)
IL05 H1N1
Primary 5/5 (211) 5/5 (211)
Contact 5/5 (106) 5/5 (106)
Number positive with reciprocal HI ≥ 40/total tested (geometric mean
reciprocal titer against homologous antigen).
with IL05 had significant cross-reactivity against NC05, IL07,
and MN07 spanning some but not all of the representative
viruses in the δ sub-clusters. In general, the antigenic cross-
reactivity is consistent with phylogenetic evidence of 2 sub-
clusters of δ-H1 influenza A viruses of swine, although the
antigenic variability appears to be complex.
4. Discussion
Classical H1N1 influenza A viruses were the main cause of
swine influenza in North America until 1998. Since the emer-
gence of viruses possessing the TRIG cassette, an increase in
the rate of genetic change in North American swine influenza
isolates appears to have occurred in H1 virus subtypes, and
Table 2: Geometric mean reciprocal titers from cross-HI assays
using δ1 or δ2 H1 influenza viruses of 21 dpi serum from primary
inoculated pigs. Viruses are listed in the far left column and antisera
are listed in the top row. Homologous titers are in bold.
TX08 IL05 MN07
δ1 H1N2 δ2 H1N1 δ2 H1N1
δ1
IL07 106 70 61
TX08 106 <10 <10
MN08 26 <10 <10
δ2
IL05 53 211 53
NC05 80 160 61
MN07 40 160 211
distinct genetic and antigenic clusters have evolved [13].
The introduction of human origin surface glycoproteins in
the TRIG backbone further complicated the swine influenza
epidemiology in North America. Human-like H1 influenza
viruses were first identified in pigs in Canada in 2003-2004
[4]. In the USA, human-like isolates began to be identified
in swine in 2005 [6]. Full-genome sequencing characterized
these as triple reassortants with the TRIG constellation
similar to that of the contemporary triple reassortant H3N2,
H1N1, and H1N2 viruses in North American swine, but with
HA and NA most similar to human seasonal H1 influenza
virus lineages [6]. Until recently, isolation of human-lineage
H1 viruses from swine has been rare in comparison with
classical swine-lineage and avian-lineage viruses. However,
epidemiological data from 2009 and 2010 years suggest that
the human-lineage H1 viruses have become one of the most
frequently detected genotype in swine herds in the USA
[14]. Therefore, a comparative experimental study in pigs
of isolates from diﬀerent phylogenetic sub-clusters, year of
isolation, and geographic region was necessary since little
is described about the biological properties of this newly
emerged group of swine viruses.
Our study indicates that the three isolates of δ-cluster
H1 influenza A viruses evaluated can eﬃciently repli-
cate, transmit, cause lung pathology, and induce humoral
immune responses in a experimental study in the swine host.
However, the kinetics of virus replication, pathogenesis, as
well as host humoral immune response diﬀered among the
three viruses, with TX08 being more virulent. A previous
study from our group evaluated the pathogenicity and
transmission properties of the human-like δ-cluster H1N1
MN07 (A/sw/MN/07002083/07) in comparison to a 2004
reassortant H1N1 (A/sw/IA/00239/04) with swine lineage
HA and NA [6]. The MN07 isolate induced disease typical of
influenza virus and was transmitted to contact pigs; however,
it replicated less extensively than the 2004 H1N1 [6].
Herein, we compared three δ-cluster H1 influenza A
virus isolates in pigs, including the MN07 isolate described
in the previous study. Our report is the first study comparing
the pathogenesis and transmission of both sub-clusters of the
δ-cluster H1 influenza viruses in swine. All isolates induced
disease typical of influenza virus and were transmitted to
contact pigs, as demonstrated by nasal swab virus isolation
and seroconversion. However, clinical signs as well as
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macroscopic lung lesions induced by MN07 were less severe
than in TX08-infected pigs. MN07-infected pigs had lower
virus titers in the lung than the TX08 and IL05 groups as
demonstrated by virus titers in BALF at 5 dpi. TX08 virus
was more eﬃcient in nasal shedding and transmission to
contact pigs. Additionally, all contact pigs were seropositive
by 12 dpc, with reciprocal HI titers ranging from 40 to 160.
Comparison of replication kinetics in the upper respiratory
tract via nasal secretions also showed diﬀerences among the
three isolates. All viruses were able to replicate and transmit;
however, TX08 nasal shedding in contact pigs was at higher
titers in a greater percentage with an extended duration.
Multistep growth analysis in MDCK cells revealed that TX08
had higher titers at 24 hours post infection with respect to
IL05 and MN07.
Quantitative analysis of viral RNA in oral fluids showed
diﬀerent kinetics of detection in comparison with nasal
swabs as TX08 samples presented higher viral RNA levels in
oral fluids but were of shorter duration when compared with
MN07 and IL05. The higher quantity, but shorter duration,
of detection of influenza RNA from OF in the TX08 group
is likely explained by the severity of clinical signs in pigs
inoculated with this isolate. Clinically aﬀected, lethargic pigs
are less likely to chew on the cotton fiber rope used to collect
the oral fluids.
Humoral responses to IL05 and TX08 were inversely
related to virus titers in nasal swabs. Pigs in this study
mounted a more robust humoral response by HI titers to
MN07 and IL-05 δ2-cluster H1N1 compared to the TX08
H1N2. Cross-HI using heterologous virus demonstrated
little cross-reactivity between antisera and viruses from
diﬀerent H1 δ sub-clusters. Based on phylogenetic and
antigenic analysis, two sub-clusters of the δ-cluster H1
influenza A viruses appear to have emerged in swine within
a period of 2 years with limited serologic cross-reactivity
between them. The viruses adopted in this study show amino
acid diﬀerences in all putative encoded proteins (data not
shown). None of these diﬀerences involve residues that have
been previously shown to modulate either pathogenicity
or transmission in pigs. Noteworthy, TX08 shows 187N
(H1 numbering) in the HA protein compared to 187D of
MN07 and IL05. D187N is a substitution often acquired
by the human seasonal H1. It has been recently shown
that a reverse-genetics recombinant human seasonal virus
containing D187N retained the binding activity to the α2-
6 linked sialosides recognized by the 187D virus; however, it
acquired the capability to bind a wide range of α2-3-linked
sialosides [15, 16]. Since pigs express both α2-6 and α2-3
receptors, D187N may have played a role in the pathogenesis
of TX08, possibly through increased receptor binding activity
in the lower respiratory tract, where α2-3 receptors have been
shown to colocalize with α2-6 receptors [17, 18].
Based on sequence prediction, TX08 should express the
full-length PB1-F2 accessory protein whereas the remaining
two viruses have premature truncations encoded in the gene.
How the presence of full-length PB1-F2 can influence the
pathogenesis of swine influenza viruses in the swine host is
still unclear and further experiments are warranted.
5. Conclusions
The findings of this study demonstrate the diversity and
continuous evolution of influenza A viruses of swine, as well
as varying pathogenicity and ability to replicate and transmit
to contact pigs. Not only are these findings important for
swine health, but they may have implications for human
health as well. Since the seasonal H1N1 component of the
trivalent human vaccine was replaced by the 2009 pandemic
H1N1 virus, the human population immunity to seasonal
H1N1 may begin to wane. As a result of waning immunity,
the human population may become more susceptible to
variant H1 viruses that have adapted and evolved in other
hosts. Therefore, it will be necessary tomonitor the evolution
of the δ-cluster viruses in the swine population as they may
become a possible reservoir for spillover back into the human
population. Furthermore, determination of virulence, adap-
tation, and transmission factors of influenza virus in the
swine host are critical for risk assessment of viruses emerging
the swine host as well as risk to humans.
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